Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Doering

Showing results (131-140 of 177) with videos related to

Pageof 18
Sort By:
Neurorehabilitation|February 15, 2014
Functional ambulation performance testing of adults with Down syndromeH R Gretz, L L Doering, J Quinn, et al.
Mbio|February 2, 2017
Trojan Horse Transit Contributes to Blood-Brain Barrier Crossing of a Eukaryotic PathogenFelipe H Santiago-Tirado, Michael D Onken, John A Cooper, et al.
Genetics|November 1, 2024
Leveraging a new data resource to define the response of Cryptococcus neoformans to environmental signalsYu Sung Kang, Jeffery Jung, Holly L Brown, et al.
Gynecologic Oncology|January 4, 2001
Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancerC Tecimer, D L Doering, L J Goldsmith, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancerC. Tecimer, D. L. Doering, L. J. Goldsmith, et al.
Chromosoma|October 1, 1995
Chromosomal locations of major tRNA gene clusters of Xenopus laevisS Narayanswami, J L Doering, F J Fokta, et al.
Genome Research|October 14, 2004
Gene prediction and verification in a compact genome with numerous small intronsAaron E Tenney, Randall H Brown, Charles Vaske, et al.
Drug Intelligence & Clinical Pharmacy|October 1, 1986
Effect of concomitant antacid administration on plasma cimetidine concentrations during repetitive dosingD W Shelly, P L Doering, W L Russell, et al.
Gynecologic Oncology|April 1, 1997
Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell linesR K Gibb, D D Taylor, T Wan, et al.
Cancer|February 15, 1996
Quantitative analyses of epidermal growth factor receptors, HER-2/neu oncoprotein and cathepsin D in nonmalignant and malignant uteriJ S Sanfilippo, S Miseljic, A R Yang, et al.
Pageof 18

Showing results (131-140 of 177) with videos related to

Sort By:
Pageof 18
Neurorehabilitation|February 15, 2014
Functional ambulation performance testing of adults with Down syndromeH R Gretz, L L Doering, J Quinn, et al.
Mbio|February 2, 2017
Trojan Horse Transit Contributes to Blood-Brain Barrier Crossing of a Eukaryotic PathogenFelipe H Santiago-Tirado, Michael D Onken, John A Cooper, et al.
Genetics|November 1, 2024
Leveraging a new data resource to define the response of Cryptococcus neoformans to environmental signalsYu Sung Kang, Jeffery Jung, Holly L Brown, et al.
Gynecologic Oncology|January 4, 2001
Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancerC Tecimer, D L Doering, L J Goldsmith, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancerC. Tecimer, D. L. Doering, L. J. Goldsmith, et al.
Chromosoma|October 1, 1995
Chromosomal locations of major tRNA gene clusters of Xenopus laevisS Narayanswami, J L Doering, F J Fokta, et al.
Genome Research|October 14, 2004
Gene prediction and verification in a compact genome with numerous small intronsAaron E Tenney, Randall H Brown, Charles Vaske, et al.
Drug Intelligence & Clinical Pharmacy|October 1, 1986
Effect of concomitant antacid administration on plasma cimetidine concentrations during repetitive dosingD W Shelly, P L Doering, W L Russell, et al.
Gynecologic Oncology|April 1, 1997
Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell linesR K Gibb, D D Taylor, T Wan, et al.
Cancer|February 15, 1996
Quantitative analyses of epidermal growth factor receptors, HER-2/neu oncoprotein and cathepsin D in nonmalignant and malignant uteriJ S Sanfilippo, S Miseljic, A R Yang, et al.
Pageof 18